Predicting changes in clinical status of young asthmatics: Clinical scores or objective parameters?

Pediatric Pulmonology

Volumn 44, Issue 5, 2009, Pages 442-449

  Leung, Ting F ^a   Ko, Fanny W S ^a   Wong, Gary W K ^a   Li, Chung Y ^a   Yung, Edmund ^a   Hui, David S C ^a   Lai, Christopher K W ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Asthma; Childhood asthma control test; Exacerbation; Prediction

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID DERIVATIVE; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

ARTICLE; ASTHMA; CHILD; CLINICAL ASSESSMENT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SPIROMETRY;

CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; SPIROMETRY; STATUS ASTHMATICUS;

EID: 66749163162     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20977     Document Type: Article

References (30)

1. Wong GW, Leung TF, Ko FW, Lee KK, Lam P, Hui DS, Fok TF, Lai CK. Declining asthma prevalence in Hong Kong Chinese schoolchildren. Clin Exp Allergy 2004;34:1550-1555.
2. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention, November 2006. Available at: http://www.ginasthma. org.
3. Expert Panel Report 3 (EPR-3). Guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 2007;120:S94-S138.
4. Centers for Disease Control and Prevention. Asthma prevalence and control characteristics by race/ethnicity-United States, 2002. MMWR 2004;53:145 -148.
5. Moy JN, Grant EN, Turner-Roan K, Li T, Weiss KB. Asthma care practices, perceptions, and beliefs of Chicago-area asthma specialists. Chicago Asthma Surveillance Initiative Project Team. Chest 1999;116:154S-162S.
6. Warman KL, Silver EJ, McCourt MP, Stein RE. How does home management of asthma exacerbations by parents of inner-city children differ from NHLBI guideline recommendations? Pediatrics 1999;103:422-427.
7. Vollmer WM. Assessment of asthma control and severity. Ann Allergy Asthma Immunol 2004;93:409-414.
8. Wijnhoven HAH, Kriegsman DMW, Hesselink AE, Penninx BW, de Haan M. Determinants of different dimensions of disease severity in asthma and COPD: pulmonary function and health-related quality of life. Chest 2001;119:1034-1042.
9. Moy ML, Israel E, Weiss ST, Juniper EF, Dube L, Drazen JM, the NHLBI Asthma Clinical Research Network. Clinical predictors of health-related quality of life depend on asthma severity. Am J Respir Crit Care Med 2001;163:924-929.
10. Annett RD, Bender BG, Lapidus J, Duhamel TR, Lincoln A. Predicting children's quality of life in an asthma clinical trial: what do children's reports tell us? J Pediatr 2001;139:854-861.
11. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the Asthma Control Test: a survey for assessing asthma control. J Allergy Clin Immunol 2004;113:59-65.
12. Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, Kosinski M, Pendergraft TB, Jhingran P. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 2006; 117:549 -556.
13. Liu AH, Zeiger R, Sorkness C, Mahr T, Ostrom N, Burgess S, Rosenzweig JC, Manjunath R. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol 2007;119:817-825.
14. American Thoracic Society, Medical Section of the American Lung Association. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-244.
15. Brooks SM, Berstein L, Raghuprasad PK, Maccia CA, Miecz- kowski L. Assessment of airway hyperresponsiveness in chronic stable asthma. J Allergy Clin Immunol 1990;85:17-26.
16. Pauwels RA, Lofdahl C-G, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A, for the Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997;337:1405-1411.
17. Baraldi E, de Jongste JC, on behalf of the ERS/ATS Task Force. Measurement of exhaled nitric oxide in children. Eur Respir J 2002;20:223-237.
18. Ip MS, Karlberg EM, Karlberg JP, Luk KD, Leong JC. Lung function reference values in Chinese children and adolescents in Hong Kong. I. Spirometric values and comparison with other populations. Am J Respir Crit Care Med 2000;162:424-429.
19. O'Connor RD. State of asthma care in the United States. Adv Stud Med 2002;2:230-235.
20. Lai CK, De Guia TS, Kim YY, Kuo S-H, Mukhopadhyay A, Soriano JB, Trung PL, Zhong NS, Zainudin N, Zainudin BM, on behalf of the Asthma Insights Reality in Asia-Pacific Steering Committee. Asthma control in the Asia-Pacific region: the Asthma Insights and Reality in Asia-Pacific Study. J Allergy Clin Immunol 2003;111:263-268.
21. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999;14:902-907.
22. Jones SL, Kittelson J, Cowan JO, Flannery EM, Hancox RJ, McLachlan CR, Taylor DR. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 2001;164:738-743.
23. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005;352:2163-2173.
24. Pijnenburg MW, Bakker EM, Hop WC, de Jongste JC. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med 2005; 172:831 -836.
25. Shaw DE, Berry MA, Thomas M, Green RH, Brightling CE, Wardlaw AJ, Pavord ID. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med 2007;176:231 -237.
26. Murray CS, Poletti G, Kebadze T, Morris J, Woodcock A, Johnston SL, Custovic A. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 2006;61:376-382.
27. Chang CH, Sharp LK, Kimmel LG, Grammer LC, Kee R, Shannon JJ. A 6-item brief measure for assessing perceived control of asthma in culturally diverse patients. Ann AllergyAsthma Immunol 2007;99:130-135.
28. Van Dellen QM, Stronks K, Bindels PJ, Ory FG, Bruil J, Van Aalderen WM, the Peace Study Group. Health-related quality of life in children with asthma from different ethnic origins. J Asthma 2007;44:125 -131.
29. Rand C, Bilderback A, Schiller K, Edelman J, Hustad C, Zeiger R, MIAMI Study Research Group. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial. J Allergy Clin Immunol 2007;119:916-923.
30. Bender BG, Bartlett SJ, Rand CS, Turner C, Wamboldt FS, Zhang L. Impact of interview mode on accuracy of child and parent report of adherence with asthma-controller medication. Pediatrics 2007;120:e471 -e477.